HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+5.45%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.69B
AUM Growth
+$2.69B
(+9.1%)
Cap. Flow
+$99M
Cap. Flow
% of AUM
3.68%
Top 10 Holdings %
Top 10 Hldgs %
40.81%
Holding
106
New
52
Increased
14
Reduced
12
Closed
23
Top Buys
| 1 |
Danaher
DHR
|
$121M |
| 2 |
Incyte
INCY
|
$91.4M |
| 3 |
Encompass Health
EHC
|
$82.3M |
| 4 |
Cencora
COR
|
$68.9M |
| 5 |
Petco
WOOF
|
$68.4M |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$100M |
| 2 |
Cooper Companies
COO
|
$89.3M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$81.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$80.5M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$77.7M |
Sector Composition
| 1 | Healthcare | 88.14% |
| 2 | Real Estate | 4.75% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 1.64% |
| 5 | Technology | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $159M | 5.62% | 1,725,650 -392,440 | -19% | -$36.1M |
|
2
Vertex Pharmaceuticals
VRTX
$100B
| $143M | 5.07% | 666,460 +83,170 | +14% | +$17.9M |
|
3
Zimmer Biomet
ZBH
$21B
| $122M | 4.3% | 759,680 +208,296 | +38% | +$33.3M |
|
|
4
Danaher
DHR
$147B
| $121M | 4.27% | +535,670 | New | +$121M |
|
5
Humana
HUM
$36.5B
| $105M | 3.73% | 251,390 +31,209 | +14% | +$13.1M |
|
6
Medtronic
MDT
$119B
| $94M | 3.33% | 796,110 +191,960 | +32% | +$22.7M |
|
|
7
Incyte
INCY
$16.5B
| $93M | 3.29% | 1,144,287 +1,124,757 | +5,759% | +$91.4M |
|
8
McKesson
MCK
$85.4B
| $92.3M | 3.27% | 473,330 +50,530 | +12% | +$9.86M |
|
9
Maravai LifeSciences
MRVI
$350M
| $86M | 3.04% | 2,412,712 -722,000 | -23% | -$25.7M |
|
|
10
Encompass Health
EHC
$12.3B
| $82.3M | 2.91% | +1,005,316 | New | +$82.3M |
|
11
Agios Pharmaceuticals
AGIO
$2.19B
| $79.2M | 2.8% | 1,532,960 +535,890 | +54% | +$27.7M |
|
12
AbbVie
ABBV
$372B
| $78.9M | 2.79% | 729,420 -124,230 | -15% | -$13.4M |
|
13
HCA Healthcare
HCA
$94.5B
| $78.2M | 2.77% | 414,990 -296,250 | -42% | -$55.8M |
|
14
IQVIA
IQV
$32.4B
| $77.6M | 2.74% | 401,690 -401,620 | -50% | -$77.6M |
|
|
15
Cencora
COR
$56.5B
| $68.9M | 2.44% | +583,290 | New | +$68.9M |
|
|
16
Petco
WOOF
$1.12B
| $68.4M | 2.42% | +3,088,000 | New | +$68.4M |
|
17
Zoetis
ZTS
$69.3B
| $66.4M | 2.35% | +421,860 | New | +$66.4M |
|
18
Welltower
WELL
$113B
| $66.4M | 2.35% | 927,040 +569,920 | +160% | +$40.8M |
|
19
Ventas
VTR
$30.9B
| $61.3M | 2.17% | 1,149,860 +491,510 | +75% | +$26.2M |
|
20
Envista
NVST
$3.52B
| $58.6M | 2.07% | 1,435,370 +396,080 | +38% | +$16.2M |
|
21
DexCom
DXCM
$29.5B
| $51.1M | 1.81% | +142,110 | New | +$51.1M |
|
22
BioCryst Pharmaceuticals
BCRX
$1.74B
| $49.7M | 1.76% | +4,886,440 | New | +$49.7M |
|
23
Boston Scientific
BSX
$156B
| $45.4M | 1.61% | +1,174,820 | New | +$45.4M |
|
|
24
Cooper Companies
COO
$13.4B
| $43.5M | 1.54% | 113,167 -232,463 | -67% | -$89.3M |
|
25
Qiagen
QGEN
$10.1B
| $40.8M | 1.44% | +838,414 | New | +$40.8M |
|